Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu|March 21, 2006
[Preparation and room temperature emission of nanocrystalline ZnO: Er3+]Shu-Chen Lu, Hong-Wei Song, Shi-Hua Huang
Hu Li Za Zhi the Journal of Nursing|October 26, 2011
[The experiences of caregivers caring for children with cord blood transplantation]Shu-Chen Lu, Tang-Her Jaing, Yu-Chuan Wen, et al.
Endocrine Reviews|September 13, 2019
Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists?Elizabeth A Killion, Shu-Chen Lu, Madeline Fort, et al.
Chemical Biology & Drug Design|October 22, 2009
Resveratrol is not a direct activator of SIRT1 enzyme activityDirk Beher, John Wu, Suzanne Cumine, et al.
Assay and Drug Development Technologies|May 21, 2010
Strategy for the identification of GPR23/LPA4 receptor agonists and inverse agonistsSoo Hang Wong, Rommel Mallari, Melissa Graham, et al.
Molecular Pharmacology|January 9, 2009
An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in miceShu-Chen Lu, Jing Xu, Narumol Chinookoswong, et al.
Journal of Lipid Research|January 31, 2012
An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in miceShu-Chen Lu, Larissa Atangan, Ki Won Kim, et al.
Annals of Hematology|June 26, 2012
Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomasTung-Liang Lin, Ming-Chung Kuo, Lee-Yung Shih, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 27, 2009
Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effectsJing Xu, Shanaka Stanislaus, Narumol Chinookoswong, et al.
Pageof 2